Recruiting

Testing a new lab tool to quickly detect four common respiratory viruses

Plain-English translation of NCT06672692 on ClinicalTrials.gov ↗ · Source last updated November 2024 · Translation generated June 2026 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

What is this trial?

Researchers are testing a new laboratory diagnostic tool called the LIAISON NES FLU A/B, RSV & COVID-19 assay that can detect and identify four common respiratory viruses (flu A, flu B, RSV, and COVID-19) from a simple nasal swab. The goal is to confirm that this new test works accurately and reliably so it can help doctors quickly diagnose what's causing a patient's respiratory illness.

Currently, when someone has respiratory symptoms, it can take time to figure out which virus they have. A faster, more accurate test that can identify all four viruses at once would help doctors give patients the right care more quickly.

Do you qualify?

You likely qualify if…

you have active signs or symptoms of a respiratory infection at the time of specimen collection
you are hospitalized, visiting an emergency department, going to an outpatient clinic, or living in a long-term care facility
a healthcare professional collects your nasal swab (or in some cases you self-collect it under professional supervision)
your specimen is properly stored in the correct transport media and at the right temperature before testing

You likely don't qualify if…

your specimen was collected using the wrong type of swab
your specimen was not stored at the recommended temperature
your specimen has been frozen and thawed more than twice
your specimen is damaged, leaking, or dried out

What participation looks like

If you qualify, a healthcare professional will collect a nasal swab from you (or you may be guided to self-collect it) at your hospital, clinic, or care facility. Your swab will then be tested with the new diagnostic tool and compared to standard testing methods. The study is collecting up to 1,000 specimens from people with respiratory symptoms to make sure the new test works accurately.

AI-generated summary from trial data · Jun 3, 2026 · Not medical advice

Testing a new lab tool to quickly detect four common respiratory viruses

What is this trial?

Do you qualify?

What participation looks like

Trial locations